This article, published in UroToday this week, is a nice summary of the latest treatments available or in development for clear cell renal cell carcinoma and non-clear cell renal cell carcinoma.
The evolving management of advanced renal cell carcinoma
7 Dec 2017
Afinitor
avelumab
axitinib
Cabometyx
cabozantinib
checkpoint inhibitors
everolimus
immunotherapy
Inlyta
ipilimumab
Keytruda
Kisplyx
lenvatinib
nivolumab
non-clear cell kidney cancer
Opdivo
pembrolizumab
renal cell carcinoma
sunitinib
Sutent
TKIs
Yervoy
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo sunitinib Sutent progression-free survival cabozantinib biomarkers NHS England Cabometyx ipilimumab COVID-19 pembrolizumab cancer survival axitinib VEGF inhibitors non-clear cell kidney cancer Inlyta coronavirus Yervoy risk factors Keytruda metastases adjuvant therapy biological markers targeted therapy papillary RCC everolimus Afinitor ASCO cancer outcomes first-line treatment NICE partial nephrectomyArchives
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec